Evidence of meeting #38 for Health in the 41st Parliament, 1st Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was drug.

A recording is available from Parliament.

On the agenda

MPs speaking

Also speaking

  • Brian O'Rourke  President and Chief Executive Officer, Canadian Agency for Drugs and Technologies in Health
  • Jeff Poston  Executive Director, Canadian Pharmacists Association
  • Joel Lexchin  Professor, School of Health Policy and Management, York University, As an Individual
  • Jeff Morrison  Director, Government Relations and Public Affairs, Canadian Pharmacists Association
  • Paul Glover  Assistant Deputy Minister, Health Products and Food Branch, Department of Health

8:45 a.m.

Conservative

The Chair Joy Smith

I call the meeting to order.

Good morning, ladies and gentlemen. I want to welcome our guests.

Pursuant to Standing Order 108(2), we're doing a study of the role of government and industry in determining drug supply in Canada.

With us—

8:45 a.m.

NDP

Libby Davies Vancouver East, BC

Madam Chair, I have a motion I'd like to move.

8:45 a.m.

Conservative

The Chair Joy Smith

Yes?

8:45 a.m.

NDP

Libby Davies Vancouver East, BC

I offer my excuses to the witnesses, but I want to make sure we deal with this motion. I raised it at the last meeting.

8:45 a.m.

Conservative

The Chair Joy Smith

We're having committee business at the end of the—

8:45 a.m.

NDP

Libby Davies Vancouver East, BC

Yes, I know, but I still would like to move the motion now to make sure that it gets done. I think we could look at the timing in camera—

8:45 a.m.

Conservative

The Chair Joy Smith

Go ahead, Mr. Strahl.

April 3rd, 2012 / 8:45 a.m.

Conservative

Mark Strahl Chilliwack—Fraser Canyon, BC

I'd like to speak to this.

8:45 a.m.

NDP

Libby Davies Vancouver East, BC

Madam Chair, I'd like to move that in relation to its study of the role of government and industry in determining drug supply in Canada, the committee report its findings to the House of Commons.

When we agreed to do this study, the motion did not spell out that we would report our findings. I assume that everybody would want to do that; otherwise, why would we be hearing all of the witnesses? However, just to be clear, we should report our findings to the House.

If this motion is approved, which I hope it will be when we deal with committee business, then we could discuss the timing. I know we have other things on the go, so we can look at the actual timing of when we would have that meeting.

8:45 a.m.

Conservative

The Chair Joy Smith

I understand the motion.

Go ahead, Mr. Strahl.

8:45 a.m.

Conservative

Mark Strahl Chilliwack—Fraser Canyon, BC

Yes, I agree that we should report on these meetings. I would just want the motion to reflect the fullness of the original motion, so I will move an amendment.

Here it reads, “that in relation to its study of the role of government and industry...”, etc. The actual motion was that the committee “examine the role of government and industry in determining drug supply in Canada, how the provinces and territories determine what drugs are required in their jurisdiction, how the industry responds to them, and the impact this has on stakeholders”.

I would certainly want all of that to be reflected in the motion when we consider the reporting on it.

8:45 a.m.

Conservative

The Chair Joy Smith

To be clear, what you're trying to say is that we'll have the complete motion as introduced by Ms. Davies, but your amendment covers....

Could you go over your amendment again, please?

8:45 a.m.

Conservative

Mark Strahl Chilliwack—Fraser Canyon, BC

Yes.

8:45 a.m.

Conservative

The Chair Joy Smith

Is this an addition to what is in her motion?

8:45 a.m.

Conservative

Mark Strahl Chilliwack—Fraser Canyon, BC

Right. It would be an addition to capture the original motion that we agreed upon when we launched this study.